These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 30557103)

  • 1. Investigation of galectin-3 levels in diabetic foot ulcers.
    Gunes AE; Eren MA; Koyuncu I; Taskin A; Sabuncu T
    J Wound Care; 2018 Dec; 27(12):843-848. PubMed ID: 30557103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between plasma angiogenic growth factors and diabetic foot ulcers.
    Chen Z; Fu S; Wu Z; Chen J; Huang Y; Wang Y; Fu M
    Clin Chim Acta; 2018 Jul; 482():95-100. PubMed ID: 29614308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of circulating soluble fms-like tyrosine kinase-1 in patients with diabetic foot ulcer: A possible mechanism of pathogenesis via a novel link between oxidative stress, inflammation and angiogenesis.
    Abd El-Khalik SR; Hafez YM; Elkholy RA
    Microvasc Res; 2020 Jul; 130():103987. PubMed ID: 32035919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiopoietin-like 2 is a potential biomarker for diabetic foot patients.
    Wang Y; Zheng Z; Yang Y; Lang J; Zhang N; Yang L; Zhao D
    BMC Endocr Disord; 2020 Nov; 20(1):178. PubMed ID: 33256685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating endothelial progenitor cells and angiogenic factors in diabetes complicated diabetic foot and without foot complications.
    Kulwas A; Drela E; Jundziłł W; Góralczyk B; Ruszkowska-Ciastek B; Rość D
    J Diabetes Complications; 2015 Jul; 29(5):686-90. PubMed ID: 25872462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evidence for elevated levels of caveolin-1 in circulation of patients with diabetic foot ulcers.
    Sheng Q; Li G; Liu H; Liu P
    Wound Repair Regen; 2022 Jan; 30(1):107-116. PubMed ID: 34847261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of low-intensity direct current on expression of vascular endothelial growth factor and nitric oxide in diabetic foot ulcers.
    Mohajeri-Tehrani MR; Nasiripoor F; Torkaman G; Hedayati M; Annabestani Z; Asadi MR
    J Rehabil Res Dev; 2014; 51(5):815-24. PubMed ID: 25509057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship of the endothelial nitric oxide synthase (eNOS) and vascular endothelial growth factor (VEGF) gene polymorphism in Turkish type 2 diabetic patients with and without diabetic foot ulcers.
    Erdogan M; Kulaksizoglu M; Tetik A; Solmaz S; Kucukaslan AS; Eroglu Z
    Foot (Edinb); 2018 Dec; 37():5-10. PubMed ID: 30321858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of miR-217 and HIF-1α/VEGF pathway in patients with diabetic foot ulcer and its effect on angiogenesis of diabetic foot ulcer rats.
    Lin CJ; Lan YM; Ou MQ; Ji LQ; Lin SD
    J Endocrinol Invest; 2019 Nov; 42(11):1307-1317. PubMed ID: 31079353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenic effects of low-intensity cathodal direct current on ischemic diabetic foot ulcers: A randomized controlled trial.
    Asadi MR; Torkaman G; Hedayati M; Mohajeri-Tehrani MR; Ahmadi M; Gohardani RF
    Diabetes Res Clin Pract; 2017 May; 127():147-155. PubMed ID: 28371685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of biomarkers in predicting diabetes complications with special reference to diabetic foot ulcers.
    Pichu S; Patel BM; Apparsundaram S; Goyal RK
    Biomark Med; 2017 Apr; 11(4):377-388. PubMed ID: 28326825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poorly designed research does not help clarify the role of hyperbaric oxygen in the treatment of chronic diabetic foot ulcers.
    Mutluoglu M; Uzun G; Bennett M; Germonpré P; Smart D; Mathieu D
    Diving Hyperb Med; 2016 Sep; 46(3):133-134. PubMed ID: 27723012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in circulating angiogenic and anti-angiogenic factors in type 2 diabetic patients with neuropathy.
    Motawi TK; Rizk SM; Ibrahim IA; El-Emady YF
    Cell Biochem Funct; 2014 Mar; 32(2):155-63. PubMed ID: 23913471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of diabetic foot ulcers with chronic vascular diabetic complications in patients with type 2 diabetes.
    Megallaa MH; Ismail AA; Zeitoun MH; Khalifa MS
    Diabetes Metab Syndr; 2019; 13(2):1287-1292. PubMed ID: 31336479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between serum galectin-3 levels and coronary atherosclerosis and plaque burden/structure in patients with type 2 diabetes mellitus.
    Ozturk D; Celik O; Satilmis S; Aslan S; Erturk M; Cakmak HA; Kalkan AK; Ozyilmaz S; Diker V; Gul M
    Coron Artery Dis; 2015 Aug; 26(5):396-401. PubMed ID: 25887000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High cystatin C levels predict undesirable outcome for diabetic foot ulcerations.
    Ai L; Hu Y; Zhang X; Zeng H; Zhao J; Zhao J; Chai Y; Lu J; Tang J; Bao Y; Liu F; Jia W
    Wound Repair Regen; 2016 May; 24(3):560-7. PubMed ID: 26864251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of Tetrahydrobiopterin Pathway in the Assessment of Diabetic Foot Ulcer: Significant and Complex Interrelations.
    Al-Nimer M; Ratha R; Mahwi T
    J Diabetes Res; 2019; 2019():3426878. PubMed ID: 31828160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Mineral Pathophysiology in Patients with Diabetic Foot Ulcer.
    Yadav C; Srikantiah RM; Manjrekar P; Shenoy MT; Chaudhury D
    Biol Trace Elem Res; 2020 Jun; 195(2):366-372. PubMed ID: 31435884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Intravitreal Aflibercept on Galectin-1 and Vascular Endothelial Growth Factor-A Plasma Levels in Patients with Diabetic Retinopathy.
    Waltl I; Zehetner C; Seifarth C; Handle F; Kieselbach GF; Angermann R; Kralinger MT
    Curr Eye Res; 2018 Mar; 43(3):368-375. PubMed ID: 29172741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased levels of galectin-3 were associated with prediabetes and diabetes: new risk factor?
    Yilmaz H; Cakmak M; Inan O; Darcin T; Akcay A
    J Endocrinol Invest; 2015 May; 38(5):527-33. PubMed ID: 25501605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.